VAISHALI

Vaishali Pharma Share PriceVaishali Pharma

₹141.3
-0.75 (-0.53%)
As on 03 December, 2023 | 05:37 BSE: NSE: VAISHALIISIN: INE972X01014

Vaishali Pharma Performance

Day Range

  • Low 141.00
  • High 147.00
₹ 141.3

52 Week Range

  • Low 114.85
  • High 193.75
₹ 141.3
  • Open Price142.35
  • Previous Close142.05
  • Volume148803

Start SIP in Vaishali Pharma

Start SIP

Vaishali Pharma Share Price

  • Over 1 Month 2.17%
  • Over 3 Month 12.72%
  • Over 6 Month 3.78%
  • Over 1 Year 12.86%

Vaishali Pharma Key Statistics

P/E Ratio 23.4
PEG Ratio 1.2
Market Cap Cr 150
Price to Book Ratio 3.7
EPS 6.2
Dividend 0
Relative Strength Index 58.64
Money Flow Index 66.46
MACD Signal 1.05
Average True Range 5.67

Vaishali Pharma Investment Rating

  • Master Rating:
  • Vaishali Pharma has an operating revenue of Rs. 72.31 Cr. on a trailing 12-month basis. An annual revenue de-growth of -7% needs improvement, Pre-tax margin of 13% is healthy, ROE of 16% is good. The company has a reasonable debt to equity of 13%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 200DMA and around 5% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 33 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 73 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Vaishali Pharma Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 13132620131022
Operating Expenses Qtr Cr 1011251711825
Operating Profit Qtr Cr 3214321
Depreciation Qtr Cr 0000000
Interest Qtr Cr 0010111
Tax Qtr Cr 1101110
Net Profit Qtr Cr 2203220
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 7278
Operating Expenses Annual Cr 6169
Operating Profit Annual in Cr 97
Depreciation Cr 10
Interest Annual Cr 22
Tax Annual Cr 22
Net Profit Annual Cr 74
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 1
Cash from Investing Activity Annual Cr -1
Cash from Financing Annual Activity Cr 0
Net Cash Flow Annual Cr 1
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 4126
Fixed Assets Annual Cr 32
Total Non Current Assets Annual Cr 65
Total Current Assets Annual Cr 7376
Total Assets Annual Cr 7982
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 3825
ROE Annual % 1615
ROCE Annual % 2328
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1611
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Vaishali Pharma Technicals

EMA & SMA

Current Price
₹141.3
-0.75 (-0.53%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹137.86
  • 50 Day
  • ₹135.34
  • 100 Day
  • ₹133.82
  • 200 Day
  • ₹130.80
  • 20 Day
  • ₹137.67
  • 50 Day
  • ₹134.20
  • 100 Day
  • ₹131.67
  • 200 Day
  • ₹137.10

Vaishali Pharma Resistance and Support

PIVOT
₹143.1
Resistance
First Resistance 145.20
Second Resistance 149.10
Third Resistance 151.20
RSI 58.64
MFI 66.46
MACD Single Line 1.05
MACD 1.47
Support
First Resistance 139.20
Second Resistance 137.10
Third Resistance 133.20

Vaishali Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 148,803 7,148,496 48.04
Week 128,823 6,465,601 50.19
1 Month 47,056 2,641,232 56.13
6 Month 104,040 5,714,911 54.93

Vaishali Pharma Result Highlights

Vaishali Pharma Synopsis

NSE-Medical-Diversified

Vaishali Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 69.66 Cr. and Equity Capital is Rs. 10.55 Cr. for the Year ended 31/03/2023. Vaishali Pharma Ltd. is a Public Limited Listed company incorporated on 25/03/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L52310MH2008PLC181632 and registration number is 181632.
Market Cap 150
Sales 72
Shares in Float 0.77
No of funds
Yield
Book Value 3.68
U/D Vol ratio 1.1
LTDebt / Equity 13
Alpha 0.06
Beta 0.29

Vaishali Pharma

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 26.62%26.74%26.74%26.74%
Mutual Funds
Insurance Companies
Foreign Portfolio Investors
Financial Institutions/ Banks
Individual Investors 62%65.97%64.92%62.85%
Others 11.38%7.29%8.34%10.41%

Vaishali Pharma Management

Name Designation
Mr. Atul Vasani Chairman & Managing Director
Mr. Dewansh Vasani Executive Director
Mrs. Jagruti Vasani Whole Time Director
Mr. Ashvin Ganatra Independent Director
Mr. Manish Ved Independent Director
Mr. Pratik Jakhelia Independent Director

Vaishali Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Vaishali Pharma Corporate Action

Date Purpose Remarks
2023-05-22 Audited Results
2022-11-03 Quarterly Results
2022-07-25 Quarterly Results
2022-05-30 Audited Results
2022-05-04 Others To consider raising of funds issue in the ratio of 3:5 of Rs. 10/-

Vaishali Pharma FAQs

What is Share Price of Vaishali Pharma ?

Vaishali Pharma share price is ₹141 As on 03 December, 2023 | 05:23

What is the Market Cap of Vaishali Pharma ?

The Market Cap of Vaishali Pharma is ₹149.7 Cr As on 03 December, 2023 | 05:23

What is the P/E ratio of Vaishali Pharma ?

The P/E ratio of Vaishali Pharma is 23.4 As on 03 December, 2023 | 05:23

What is the PB ratio of Vaishali Pharma ?

The PB ratio of Vaishali Pharma is 3.7 As on 03 December, 2023 | 05:23

Q2FY23